Plasma-Lyte 148 (pH 7.4) Infusion Overview

What Plasma-Lyte 148 is

Plasma-Lyte 148 (pH 7.4) is a specialized intravenous solution designed to help restore fluid and electrolyte balance. It is an isotonic fluid used in hospital and emergency settings where fluid replacement is needed.

The solution is manufactured by Baxter Healthcare and is commonly discussed in relation to surgery, burns, dehydration, and critical care support.

What Plasma-Lyte 148 is used for

Plasma-Lyte 148 is primarily used for fluid replacement. In the original content, it is described as being used in situations such as:

• Burns
• Surgical procedures
• Significant fluid loss
• Severe dehydration
• Electrolyte disturbances
• Support in critically ill patients

Its balanced composition is intended to help maintain hemodynamic stability and reduce the risk of large fluid shifts during infusion therapy.

Key ingredients in Plasma-Lyte 148

The original content lists the following components:

According to the original text, the formulation has a metabolic alkalinizing effect, which may be relevant in patients with metabolic acidosis.

How it compares with normal saline

The original content highlights several differences between Plasma-Lyte 148 and normal saline:

• Normal saline contains sodium chloride only, while Plasma-Lyte 148 includes additional electrolytes.
• Plasma-Lyte 148 has buffering capacity, which may help reduce the risk of metabolic acidosis.
• Normal saline may contribute to hyperchloremic acidosis when used for extended periods.
• Plasma-Lyte 148 is described as having better compatibility with blood products.

These points are presented in the source content as general comparisons, not as a substitute for local prescribing guidance.

Dosage and administration considerations

The original article does not provide a fixed dose for every patient. It states that dosage depends on the clinical situation, age, weight, and underlying medical conditions.

It also notes a general adult and adolescent range of 500 mL to 3 liters per day. This should be interpreted only within the context of the original content and local clinical protocols.

Factors mentioned in the source include:

• Clinical condition
• Volume of fluid loss
• Age and body weight
• Need for ongoing monitoring

The original text also advises extra caution in geriatric patients and people with renal impairment.

Contraindications mentioned in the source content

The original content lists the following situations where Plasma-Lyte 148 may be unsuitable or require careful assessment:

• Hyperkalemia
• Renal failure
• Metabolic alkalosis

Because infusion decisions are clinical decisions, the official product information and a qualified prescriber should always be consulted.

Precautions to consider

The source content emphasizes several practical precautions:

• Check the packaging for damage or contamination before use.
• Monitor electrolyte levels during infusion.
• Watch for fluid overload, especially in patients with cardiac or renal issues.
• Adjust treatment based on the patient’s response and clinical monitoring.

Frequently asked questions

Safety reminder

Plasma-Lyte 148 is an intravenous medicine used in monitored clinical care. A healthcare professional should confirm the indication, infusion rate, and monitoring plan. Always refer to the official product leaflet and local hospital guidance for the most accurate information.

Summary

Plasma-Lyte 148 (pH 7.4) is a balanced infusion solution used for fluid replacement and electrolyte support. The original content describes it as containing sodium, potassium, magnesium, acetate, and gluconate components, with buffering properties that may help maintain acid-base balance. Its use, however, depends on the patient’s condition and should be guided by clinical assessment.